Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 1
2016 1
2020 1
2021 4
2022 9
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Zhanet
Page 1
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation.
Entezari M, Hashemi D, Taheriazam A, Zabolian A, Mohammadi S, Fakhri F, Hashemi M, Hushmandi K, Ashrafizadeh M, Zarrabi A, Ertas YN, Mirzaei S, Samarghandian S. Entezari M, et al. Biomed Pharmacother. 2022 Feb;146:112563. doi: 10.1016/j.biopha.2021.112563. Epub 2021 Dec 29. Biomed Pharmacother. 2022. PMID: 35062059 Free article. Review.
The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. Mirzaei S, et al. J Hematol Oncol. 2022 Mar 2;15(1):18. doi: 10.1186/s13045-022-01235-1. J Hematol Oncol. 2022. PMID: 35236381 Free PMC article. Review.
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity.
Mahabady MK, Mirzaei S, Saebfar H, Gholami MH, Zabolian A, Hushmandi K, Hashemi F, Tajik F, Hashemi M, Kumar AP, Aref AR, Zarrabi A, Khan H, Hamblin MR, Nuri Ertas Y, Samarghandian S. Mahabady MK, et al. J Cell Physiol. 2022 May;237(5):2309-2344. doi: 10.1002/jcp.30751. Epub 2022 Apr 18. J Cell Physiol. 2022. PMID: 35437787 Review.
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.
Paskeh MDA, Mehrabi A, Gholami MH, Zabolian A, Ranjbar E, Saleki H, Ranjbar A, Hashemi M, Ertas YN, Hushmandi K, Mirzaei S, Ashrafizadeh M, Zarrabi A, Samarghandian S. Paskeh MDA, et al. Biomed Pharmacother. 2022 Feb;146:112532. doi: 10.1016/j.biopha.2021.112532. Epub 2021 Dec 11. Biomed Pharmacother. 2022. PMID: 34906772 Free article. Review.
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M, Ghanbarirad M, Taheriazam A, Sadrkhanloo M, Zabolian A, Goharrizi MASB, Hushmandi K, Aref AR, Ashrafizadeh M, Zarrabi A, Nabavi N, Rabiee N, Hashemi M, Samarghandian S. Entezari M, et al. Biomed Pharmacother. 2022 Jun;150:112963. doi: 10.1016/j.biopha.2022.112963. Epub 2022 Apr 22. Biomed Pharmacother. 2022. PMID: 35468579 Free article. Review.
19 results